Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease
<p>Abstract</p> <p>Background</p> <p>A cohort study was conducted to examine the role of genetic polymorphisms in three estrogen metabolizing enzymes (<it>COMT</it>, <it>CYP1A1</it>, <it>CYP1B1</it>) and the two estrogen receptors (&l...
Main Authors: | Thuita Lucy W, Newschaffer Craig J, McSorley Meghan A, Berndt Sonja I, Gallicchio Lisa, Argani Pedram, Hoffman Sandra C, Helzlsouer Kathy J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/173 |
Similar Items
-
Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls
by: Hanna Wedad M, et al.
Published: (2008-05-01) -
Analysis of the estrogenic activities of an herbal extract on estrogen-sinsitive breast cancer cells
by: 459203 Maldonado, Alex, et al.
Published: (2000) -
Estrogen Receptor Signaling in Breast Cancer
by: Paulina Miziak, et al.
Published: (2023-09-01) -
The Relationship between Serum Estrogen Levels and Presence of Benign Lesions in Uterus Thyroid Gland and Breasts
by: Zeynep Nilufer Tekin, et al.
Published: (2019-08-01) -
Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk
by: Micaela Almeida, et al.
Published: (2021-01-01)